Certain Shares of Formycon AG are subject to a Lock-Up Agreement Ending on 2-AUG-2023.
Details:
Following the private placement, Formycon will be subject to a lock-up obligation with market-standard exemptions for a period of six months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.3 EUR | +0.18% |
|
+1.10% | -1.95% |
Jul. 01 | US FDA Approves Formycon's Biosimilar to Treat Serious Retinal Diseases | MT |
Jun. 18 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
1st Jan change | Capi. | |
---|---|---|
-1.95% | 1.06B | |
+23.50% | 47.07B | |
+47.19% | 42.06B | |
-5.16% | 39.98B | |
+36.37% | 33.02B | |
-7.79% | 27.9B | |
+18.06% | 27.63B | |
+47.29% | 14.37B | |
+41.91% | 13.45B | |
-1.02% | 12.03B |